NCT06124417View on ClinicalTrials.gov

Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression

PHASE4CompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

August 25, 2023

Study Completion Date

September 29, 2023

Conditions

Efficacy, TeamAdverse Reaction to Drug

Interventions

DRUG

Sertraline

The initial dose ranged from 25 to 50 mg, taken orally once daily, and the dosage was adjusted based on the patient's response to the medication.

Trial Locations (1)

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors

lead

First Affiliated Hospital of Chongqing Medical University

OTHER

NCT06124417 - Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression | Biotech Hunter | Biotech Hunter